Deutsch English Français

Contact

EP2742154

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP2742154

EP2742154 - BIOMARKER COMPOSITIONS AND METHODS [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 02.02.2018 Database last updated on 25.09.2024
Former	Examination is in progress Status updated on 12.05.2017
Most recent event Tooltip	02.02.2018	Application deemed to be withdrawn	published on 07.03.2018 [2018/10]
Applicant(s)	For all designated states Caris Life Sciences Switzerland Holdings GmbH St. Jakobs Strasse 199 Citygate 4052 Basel / CH
	[2014/47]
Former [2014/25]	For all designated states Caris Life Sciences Luxembourg Holdings, S.a.r.l. Rue De Maraichers L2124 Grand-duche De Luxembourg / LU
Inventor(s)	01 / BROWN, Kirk 127 Greenwood Avenue Swampscott, MA 01907 / US
	02 / PAWLOWSKI, Traci 26071 Anacapa Street Laguna Hills, CA 92653 / US
	03 / SPETZLER, David 13539 N. 95th Way Scottsdale, AZ 85260 / US
	[2015/17]
Former [2015/14]	01 / BROWN, Kirk 127 Greenwood Avenue Swampscott Massachusetts 01907 / US
	02 / PAWLOWSKI, Traci 2014 N Milkweed Loop Phoenix, AZ 85037 / US
	03 / SPETZLER, David 13539 N. 95th Way Scottsdale, AZ 85260 / US
Former [2014/25]	01 / BROWN, Kirk 14256 North Coral Gables Drive Phoenix, AZ 85023 / US
	02 / PAWLOWSKI, Traci 2014 N Milkweed Loop Phoenix, AZ 85037 / US
	03 / SPETZLER, David 13539 N. 95th Way Scottsdale, AZ 85260 / US
Representative(s)	J A Kemp LLP 80 Turnmill Street London EC1M 5QU / GB
	[N/P]
Former [2014/25]	Roques, Sarah Elizabeth J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB
Application number, filing date	12821745.2	08.08.2012
	WO2012US50030
Priority number, date	US201161521333P	08.08.2011 Original published format: US 201161521333 P
	US201161523763P	15.08.2011 Original published format: US 201161523763 P
	US201161526623P	23.08.2011 Original published format: US 201161526623 P
	US201161529762P	31.08.2011 Original published format: US 201161529762 P
	US201161534352P	13.09.2011 Original published format: US 201161534352 P
	US201161537462P	21.09.2011 Original published format: US 201161537462 P
	US201161542639P	03.10.2011 Original published format: US 201161542639 P
	US201161551674P	26.10.2011 Original published format: US 201161551674 P
	US201161559676P	14.11.2011 Original published format: US 201161559676 P
	US201261612111P	16.03.2012 Original published format: US 201261612111 P
	US201261619803P	03.04.2012 Original published format: US 201261619803 P
	[2014/25]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2013022995
	Date:	14.02.2013
	Language:	EN
	[2013/07]
	Type:	A2 Application without search report
	No.:	EP2742154
	Date:	18.06.2014
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 14.02.2013 takes the place of the publication of the European patent application.
	[2014/25]
Search report(s)	International search report - published on:	US	04.04.2013
	(Supplementary) European search report - dispatched on:	EP	13.07.2015
Classification	IPC:	C12Q1/68, G01N33/53, G01N33/50, G01N33/574, G01N33/68, G01N33/566	[2015/13]
	CPC:	G01N33/53 (EP); C12Q1/6886 (CN); G01N33/566 (EP); G01N33/574 (EP); G01N33/57434 (CN); G01N33/57484 (CN); (+) G01N33/6842 (EP); G01N33/6893 (CN); C12Q2600/158 (CN); C12Q2600/178 (CN); Y02A90/10 (EP) (-)
	Former IPC [2014/25]	C12Q1/68
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/25]
Title	German:	BIOMARKERZUSAMMENSETZUNGEN UND VERFAHREN DAMIT	[2014/25]
	English:	BIOMARKER COMPOSITIONS AND METHODS	[2014/25]
	French:	COMPOSITIONS DE BIOMARQUEURS ET PROCÉDÉS	[2014/25]
Entry into regional phase	26.02.2014	National basic fee paid
	26.02.2014	Search fee paid
	26.02.2014	Designation fee(s) paid
	26.02.2014	Examination fee paid
Examination procedure	26.02.2014	Examination requested [2014/25]
	09.02.2016	Amendment by applicant (claims and/or description)
	16.05.2017	Despatch of a communication from the examining division (Time limit: M04)
	27.09.2017	Application deemed to be withdrawn, date of legal effect [2018/10]
	25.10.2017	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2018/10]
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 16.05.2017
Fees paid	Renewal fee
	29.10.2014	Renewal fee patent year 03
	10.08.2015	Renewal fee patent year 04
	11.08.2016	Renewal fee patent year 05
	Penalty fee
	Additional fee for renewal fee
	31.08.2014	03 M06 Fee paid on 29.10.2014
	31.08.2017	06 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[X]WO2008092153 (UNIV LOUISVILLE RES FOUND [US], et al) [X] 1-7,9-15* example 2; claim 10 *;
		[X]WO2009015357 (UNIV LOUISVILLE RES FOUND [US], et al) [X] 1-4,6-15 * p10 last par;; figure 8 *;
		[X]WO2010056337 (CARIS MPI INC [US], et al) [X] 1-4,6-15 * par [00126]; par [00683];; claims 1,10,11,16,24,72 *;
		[X] - T. DENG ET AL, "Abstract 444: Subpopulations of circulating microvesicles have different microRNA profiles", CANCER RESEARCH, (20110415), vol. 71, no. 8 Supplement, doi:10.1158/1538-7445.AM2011-444, ISSN 0008-5472, pages 444 - 444, XP055168378 [X] 1-4,6-15 * abstract * DOI: http://dx.doi.org/10.1158/1538-7445.AM2011-444
		[X] - Ta Deng ET AL, "Subpopulations of Circulating Microvesicles Have Different MicroRNA Profiles", (20110407), URL: http://www.carislifesciences.com/media/pdf/Spetzler-sorted-MiRs-AACR-poster-2011.pdf, (20150209), XP055168385 [X] 1-4,6-15 * abstract *
		[X] - Traci Pawlowski ET AL, "Circulating exosomes may provide an alternate platform to monitor disease progression compared to circulating tumor cells CD-81 Labeled Exosome Level vs CTCs in Plasma Derived Exosomes miR-21 Copy Number vs CTCs in EpCAM+ Plasma Derived Exosomes", (20100705), URL: http://www.carislifesciences.com/media/pdf/ASCO_Pawlowski2010.pdf, (20150209), XP055168408 [X] 1-4,6-15 * abstract *
	International search	[Y]US2004038207 (ORNTOFT TORBEN F [DK]);
		[Y]US2005152908 (LIEW CHOONG-CHIN [CA], et al);
		[Y]US2008085524 (LOIS AUGUSTO [US]);
		[Y]US2009203533 (MUNNES MARC [DE], et al);
		[Y]US2010248225 (BANKAITIS-DAVIS DANUTE M [US], et al);
		[Y]US2010248290 (LAM STEPHEN [CA], et al);
		[X]US2011151460 (KLASS MICHAEL [US], et al);
		[Y]US2011166030 (WANG YIXIN [US], et al);
		[Y]US2011177054 (GIBBINGS DERRICK [FR], et al)

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p